MIPS researcher awarded Adrien Albert Award by RACI

Professor Jonathan Baell from the Medicinal Chemistry theme of the Monash Institute of Pharmaceutical Sciences has been awarded the prestigious Adrien Albert Award for 2018.

Professor Jonathan Baell

Professor Jonathan Baell from the Medicinal Chemistry theme of the Monash Institute of Pharmaceutical Sciences has been awarded the prestigious Adrien Albert Award for 2018.

Presented by the Royal Australian Chemical Institute (“RACI”), the Adrien Albert Award is the premier award from RACI’s Division of Medicinal Chemistry and Chemical Biology. It recognises outstanding research in the field of medicinal or agricultural chemistry or chemical biology.

The Adrien Albert award honors the late Adrien Albert, an Australian scientist who is recognised as a pioneer in the development of medicinal chemistry, having established the first Department of Medicinal Chemistry at the Australian National University.

Professor Baell, a Larkins Fellow and Co-Director of the Australian Translational Medicinal Chemistry Facility, is also President-Elect of the International Chemical Biology Society and Co-Senior Editor of the journal, Future Medicinal Chemistry.

He leads research in the field of Medicinal Chemistry, with a focus on drug discovery for infectious diseases. In 2010, Professor Baell was lead author on a paper, now cited more than 1200 times, that found new substructure filters for removal of Pan Assay Interference Compounds, also known as PAINS.

As a result of Professor Baell’s PAINS research paper, the American Chemical Society issued new protocols on any study involving PAINS. Professor Baell’s paper highlighted that PAINS have been responsible for thousands of false positives in molecule screening for medications. Professor Baell’s PAINS paper also saw an editorial in the leading scientific journal, Nature. His most recent research has addressed potential cures for Chagas disease and Leishmaniasis.

In 2017 Professor Baell, along with a coalition of researchers from MIPS, the University of Melbourne and the Indian Institute of Chemical Biology, led a proposal to investigate the development of a potential treatment for Leishmaniasis. The team were awarded the only successful grant in India and the only one awarded in drug discovery.

Professor Baell leads seven further active research projects, addressing priority areas including the phenotyping of multiple sclerosis, treatments for malaria and the development of new drugs against parasitic nematodes of livestock animals.

As part of the award, RACI will invite Professor Baell to present a plenary lecture at the upcoming RACI Medicinal Chemistry & Chemical Biology Divisional Conference, with the opportunity to discuss his topical research with the wider medicinal chemistry community.

“Jonathan continues to add to his growing list of accomplishments. This award recognises a long term sustained effort of achievements, including several dozen granted patents and involvement with programs that have progressed to clinical trials for indications that vary from multiple sclerosis to anxiety.” says Professor Chris Porter, Director of MIPS.

“We congratulate him on this milestone achievement and look forward to continued success in the future.”

Contact: Divya Krishnan

Phone: 0466 910 111

Email: divya.krishnan@monash.edu